Recently awarded the prestigious ACS Commission on Cancer Outstanding Achievement Award, South Nassau was selected for inclusion in the list based on a number of factors, including clinical outcomes, clinical expertise and cancer research.

1. For Immediate Release October 30, 2015
Contact: Damian Becker, Manager of Media Relations
(516) 377-5370
Becker’s Names South Nassau to Its 2015 List
of 100 Hospitals with Great Oncology Programs
Oceanside, N.Y. — South Nassau Communities Hospital is the only Long Island-based
hospital to be named to the Becker's Hospital Review 2015 listing of “100 Hospitals and Health
Systems With Great Oncology Programs.”
Recently awarded the prestigious American College of Surgeons Commission on Cancer
Outstanding Achievement Award, South Nassau was selected for inclusion in the list based on a
number of factors, including clinical outcomes, clinical expertise, cancer research and patient
care and safety.
"South Nassau is a mission-driven organization that does not relent in fulfilling its
promise to provide high-quality, patient-centered healthcare services,” said Richard J. Murphy,
South Nassau's president and CEO. “This honor is testimony that we are fulfilling that
commitment 365 days a year, 24 hours a day.”
“We focus on ensuring that our patients receive the high-quality, advanced cancer care
and support services that they deserve,” said Rajiv Datta, MD, FACS, FRCS, FICS, chair of the
department of surgery and medical director of the Gertrude & Louis Feil Cancer Center. “Our
program features a multidisciplinary team of world-class medical, radiation, and surgical
oncologists who work together and use an array of advanced diagnostic, medical, radiation, and
surgical oncology technologies and treatments to provide evaluation and therapy for the range of
cancers.”
The Gertrude & Louis Feil Cancer Center treats approximately 1,500 patients annually.
The center has evolved into one of the region’s premiere providers of compassionate advanced
cancer care. It is the only one on Long Island that is equipped with three of the most effective
technologies used to treat and eradicate cancer: the Varian Novalis Tx™, da Vinci® Surgical
System and Gamma Knife® Perfexion.
News From:

2. In addition to its Cancer Center in Valley Stream, NY, The Gertrude & Louis Feil Cancer
Center incorporates the following specialty cancer care services:
• GYN Oncology Department (Valley Stream)
• Long Island Gamma Knife® Center (Oceanside)
• Center for Prostate Health Program (Oceanside)
• Center for Breast Health (Oceanside)
• Center for Lung Health (Oceanside/Valley Stream)
• Radiation Oncology Department (Oceanside and Valley Stream)
• Surgical Oncology Department (Oceanside and Valley Stream)
• Complete Women’s Imaging Center at South Nassau (Oceanside)
• PET/CT Service (Oceanside)
South Nassau is a recipient of the American Heart Association/American Stroke
Association’s Get With The Guidelines®–Target: Stroke Honor Roll-Elite Quality Achievement
Award as well as the American Heart Association/American College of Cardiology Foundation
Get With The Guidelines®–Heart Failure Silver-Plus Quality Achievement Award.
Designated a Magnet® hospital by the American Nurses Credentialing Center (ANCC),
South Nassau® Communities Hospital is one of the region’s largest hospitals, with 455 beds,
more than 900 physicians and 3,000 employees. Located in Oceanside, NY, the hospital is an
acute-care, not-for-profit teaching hospital that provides state-of-the-art care in cardiac,
oncologic, orthopedic, bariatric, pain management, mental health and emergency services. In
addition to its extensive outpatient specialty centers, South Nassau provides emergency and
elective angioplasty, and is the only hospital on Long Island with the Novalis Tx™ and Gamma
Knife® radiosurgery technologies. South Nassau is a designated Stroke Center by the New York
State Department of Health and Comprehensive Community Cancer Center by the American
College of Surgeons and is an accredited center of the Metabolic and Bariatric Surgery
Association and Quality Improvement Program. In addition, the hospital has been awarded the
Joint Commission’s gold seal of approval as a Top Performer on Key Quality Measures,
including heart attack, heart failure, pneumonia and surgical care; and disease-specific care for
hip and joint replacement, wound care and end-stage renal disease. For more information, visit
www.southnassau.org.
-30-